Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGenics Renews Pathway License from Ariadne

NEW YORK, Feb. 14 (GenomeWeb News) -

 Ariadne announced today that AlphaGenics has licensed its PathwayStudio 4.0 software for use its nutrigenomic studies.

 

AlphaGenics, a Rockville, Md.-based developer of personalized consumer lifestyle and vanity products, has been using an earlier version of the software, Ariadne said.

 

Pathway Studio 4.0 comes with the ResNet database of 700,000 functional relationships and over 1,000 newly reconstructed pathways, and with the MedScan Reader biomedical literature browser.

 

Financial deals were not released.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.